Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

369

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

December 31, 2012

Conditions
Sarcoma, Soft Tissue
Interventions
DRUG

PAZOPANIB

800 mg once daily orally

DRUG

Placebo

matching placebo 800 mg once daily orally

Trial Locations (81)

1000

GSK Investigational Site, Brussels

1200

GSK Investigational Site, Brussels

2031

GSK Investigational Site, Randwick

3000

GSK Investigational Site, Leuven

3128

GSK Investigational Site, Box Hill

4000

GSK Investigational Site, Liège

4102

GSK Investigational Site, Woolloongabba

5037

GSK Investigational Site, Kurralta Park

6009

GSK Investigational Site, Nedlands

7000

GSK Investigational Site, Hobart

9000

GSK Investigational Site, Ghent

10060

GSK Investigational Site, Candiolo (TO)

10153

GSK Investigational Site, Turin

13385

GSK Investigational Site, Marseille

15526

GSK Investigational Site, Bad Saarow

19106

GSK Investigational Site, Philadelphia

20089

GSK Investigational Site, Rozzano (MI)

20133

GSK Investigational Site, Milan

20162

GSK Investigational Site, Milan

28040

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

30625

GSK Investigational Site, Hanover

33076

GSK Investigational Site, Bordeaux

35243

GSK Investigational Site, Birmingham

42271

GSK Investigational Site, Saint-Priest-en-Jarez

44106

GSK Investigational Site, Clevand

45122

GSK Investigational Site, Essen

46009

GSK Investigational Site, Valencia

50937

GSK Investigational Site, Cologne

54511

GSK Investigational Site, Vandœuvre-lès-Nancy

55455

GSK Investigational Site, Minneapolis

59020

GSK Investigational Site, Lille

60590

GSK Investigational Site, Frankfurt am Main

60657

GSK Investigational Site, Chicago

68167

GSK Investigational Site, Mannheim

69120

GSK Investigational Site, Heidelberg

69373

GSK Investigational Site, Lyon

75248

GSK Investigational Site, Paris

80131

GSK Investigational Site, Napoli

90048

GSK Investigational Site, Los Angeles

90403

GSK Investigational Site, Santa Monica

92868

GSK Investigational Site, Orange

94805

GSK Investigational Site, Villejuif

02114

GSK Investigational Site, Boston

02215

GSK Investigational Site, Boston

DK-2730

GSK Investigational Site, Herlev

01307

GSK Investigational Site, Dresden

00144

GSK Investigational Site, Rome

05100

GSK Investigational Site, Terni

464-8681

GSK Investigational Site, Aichi

260-8717

GSK Investigational Site, Chiba

811-1395

GSK Investigational Site, Fukuoka

003-0804

GSK Investigational Site, Hokkaido

514-8507

GSK Investigational Site, Mie

700-8558

GSK Investigational Site, Okayama

537-8511

GSK Investigational Site, Osaka

540-0006

GSK Investigational Site, Osaka

104-0045

GSK Investigational Site, Tokyo

1066 CX

GSK Investigational Site, Amsterdam

9713 GZ

GSK Investigational Site, Groningen

2300 RC

GSK Investigational Site, Leiden

6525 GA

GSK Investigational Site, Nijmegen

3075 EA

GSK Investigational Site, Rotterdam

705-717

GSK Investigational Site, Daegu

410-769

GSK Investigational Site, Goyang-si, Gyeonggi-do

110-744

GSK Investigational Site, Seoul

120-752

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

07010

GSK Investigational Site, Palma de Mallorca

SE413 45

GSK Investigational Site, Gothenburg

SE-581 85

GSK Investigational Site, Linköping

SE-221 85

GSK Investigational Site, Lund

SE-901 85

GSK Investigational Site, Umeå

SE-751 85

GSK Investigational Site, Uppsala

M20 4BX

GSK Investigational Site, Manchester

G12 0YN

GSK Investigational Site, Glasgow

LS9 7TF

GSK Investigational Site, Leeds

SW3 6JJ

GSK Investigational Site, London

NG5 1PB

GSK Investigational Site, Nottingham

S10 2SJ

GSK Investigational Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY